Key result
High adherence to the Enhanced Recovery After Surgery (ERAS) pathway independently reduced major morbidity and mortality rates after colorectal surgery.
Why the study?
High adherence rates to ERAS may significantly reduce major morbidity, anastomotic leakage, and mortality rates after colorectal surgery.
Does high adherence to the ERAS pathway reduce major morbidity, anastomotic leakage, and mortality rates in patients undergoing elective colorectal surgery?
Observational (n=8,359)
Yes
Does high adherence to the ERAS pathway reduce major morbidity, anastomotic leakage, and mortality rates in patients undergoing elective colorectal surgery?
High adherence (>85%) to the Enhanced Recovery After Surgery (ERAS) pathway independently reduces major morbidity and mortality rates after elective colorectal surgery.
This is the authors' abstract. We don't add key points for this paper.
Background: Enhanced recovery after surgery (ERAS) offers lower overall morbidity rates and shorter hospital stay after colorectal surgery (CRS); high adherence rates to ERAS may significantly reduce major morbidity (MM), anastomotic leakage (AL), and mortality (M) rates as well. Methods: Prospective enrollment of patients submitted to elective CRS with anastomosis in two separate 18- and 12-month periods among 78 surgical centers in Italy from 2019 to 2021. Adherence to ERAS pathway items was measured upon explicit criteria in every case. After univariate analysis, independent predictors of primary endpoints (MM, AL, and M rates) were identified through logistic regression analyses, presenting odds ratios (OR) and 95% confidence intervals. Results: An institutional ERAS status was declared by 48 out of 78 (61.5%) participating centers. The median overall adherence to ERAS was 75%. Among 8,359 patients included in both studies, MM, AL, and M rates were 6.3%, 4.4%, and 1.0%, respectively. Several patient-related and treatment-related variables showed independently higher rates for primary endpoints: male gender, American Society of Anesthesiologists class III, neoadjuvant treatment, perioperative steroids, intra- and/or postoperative blood transfusions, length of the operation >180’, surgery for malignancy. On the other hand, ERAS adherence >85% independently reduced MM (OR, 0.91) and M (OR, 0.25) rates, whereas no mechanical bowel preparation independently reduced AL (OR, 0.68) rates. Conclusions: Among other patient- or treatment-related variables, ERAS adherence >85% independently reduced MM and M rates, whereas no mechanical bowel preparation independently reduced AL rates after CRS.
Answers are grounded in this paper and cite their sources.
Supports targeting high ERAS adherence in colorectal surgery; leaves open RCT confirmation of causality.
No takes yet. Share an insight, caveat, or question.
Catarci et al. (2023) conducted an observational in Elective colorectal surgery with anastomosis (n=8,359). High adherence (>85%) to Enhanced Recovery After Surgery (ERAS) pathway vs. ERAS adherence ≤85% was evaluated on Major morbidity (Clavien-Dindo grade >II) (OR 0.84, 95% CI 0.72-0.98, p=0.028). High adherence to the Enhanced Recovery After Surgery (ERAS) pathway independently reduced major morbidity and mortality rates after colorectal surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: